FibroGenesis to use Apple Watch to leverage PneumoBlast COVID-19-related ARDS Study
<p class=""><a href="https://www.fibro-genesis.com" target="_blank" rel="noopener">FibroGenesis</a>, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts (HDFs), has announced the incorporation of Apple Watch to monitor patients through the course of global studies using PneumoBlast, for the treatment of Acute Respiratory Distress Syndrome (ARDS) in patients affected by COVID-19.</p>